Direct-Acting Oral Anticoagulants ( Rivaroxaban, apixaban and dabigatran) Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Cardiovascular disorders; Stroke; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 20 Jul 2020 New trial record
- 09 Jul 2020 Results published in the Stroke